Health policy makers aspire to achieve an HIV treatment 'cascade' in which diagnostic and treatment services are accessed early and routinely by HIV-infected individuals. However, migrants and highly mobile individuals are likely to interact with HIV treatment programs and the healthcare system in ways that reflect their movement through time and place, affecting their successful progression through the HIV treatment cascade. We review recent research that has examined the challenges in effective and sustained HIV treatment for migrants and mobile populations.
INTRODUCTION
In recent years, several studies have convincingly demonstrated that combination antiretroviral therapy (ART) can improve the life expectancy of communities experiencing severe HIV epidemics and reduce the rate of onward HIV transmission [1] [2] [3] [4] [5] . Optimism generated by these findings has been coupled with the timely development of standardized and affordable ART regimens that have reached more than 15 million people worldwide by 2015 [6] . Given these developments, the United Nations Programme on HIV/AIDS (UNAIDS) has recently proposed a set of 'ambitious but achievable' targets to have 90% of all HIV-infected people diagnosed, to ensure that 90% of those who know their status are on ART and to maintain virologic suppression for 90% of all treated individuals by the year 2020 [6] . Attention has now turned to the question of how HIV diagnostic and treatment strategies, in the context of the 90-90-90 benchmarks, can be optimized through existing public healthcare programs. Introduced in 2009, the HIV treatment cascade has since regained traction as an important concept and a useful metric with which to evaluate the implementation and success of these strategies [7, 8] .
The HIV treatment cascade envisages an ideal pathway for the infected individual through a discrete set of diagnostic and treatment stages. In the best-case scenario, an individual is diagnosed early after HIV infection in stage 1 (testing); in stages 2 and 3 (linkage and retention), the individual links to clinical care and is routinely monitored until meeting ART eligibility criteria; in stage 4 (treatment), the individual is initiated on ART soon after eligibility; in stage 5 (re-engagement), virologic suppression is maintained through long-term treatment adherence and care [7] . In reality, however, individuals are more likely to enter into the healthcare system late and are at a greater risk of lost-to-follow-up at successive stages of the treatment cascade [8-15,16 & ]. Furthermore, existing 'leaks' in the treatment cascade are being multiplied by a range of factors related to migration, mobility and frequent travel [17,18,19 & ,20,21] . Migrants are a large group of individuals (approximately 1 billion worldwide) who reside outside their country of birth [22] . This group includes labor migrants, refugees, asylum seekers, returnees and undocumented migrants who have chosen to either settle in the host country (settlers), relocate or move to another country (transit migrants), or move back and forth between their home and host countries (circular migrants). Because of their levels of high mobility, as documented elsewhere, migrants are at a higher risk of HIV acquisition and will be less likely to benefit from the survival and preventive impact of ART [23, 24] . Furthermore, an accumulating body of research has described the vulnerability of HIVinfected migrants to a wide range of social, economic and political factors that include a lack of direct access to healthcare services; exposure to difficult or oppressive work environments; the separation from family, friends and a familiar sociocultural environment [25, 26] . Migrants will require very specific health systems infrastructure and interventions to rapidly and successfully progress through the HIV treatment cascade [27] . In this article, we review recent research that has examined the challenges in effective and sustained HIV treatment for migrants and mobile populations. We then review findings related to strategies that hold promise for increasing HIV testing and HIV treatment retention and adherence in this highly vulnerable population.
CHALLENGES IN EFFECTIVE HIV TREATMENT FOR MIGRANTS
Migrants commonly have distinct health profiles that are closely linked to their social values, cultural norms and geographic backgrounds. A health profile is likely to inform the behavior of a migrant when confronted with an unfamiliar context. The health needs and expectations of the migrant are also likely to be at odds with those of the host country, which will have important implications for the timely entry into, and retention within, the HIV cascade of care. A summary of recent key qualitative and quantitative studies linking population mobility with the HIV treatment cascade is given in Table 1 [15,16 & ,28-39] .
Entry into HIV care
Over the last decade, a large body of research has shown that migrants and other highly mobile
KEY POINTS
The HIV treatment cascade is a conceptual framework that can be used to evaluate the implementation and success of systems to diagnose and treat HIVinfected individuals.
Migrants are more likely to experience disparities and inequalities in health access due to their legal (undocumented) status, unfamiliarity with the host environment, poor communication skills, and experience of culturally insensitive healthcare services and practices. Feelings of confusion, helplessness, vulnerability, fear of disclosure and suspicion of the healthcare system may further contribute to poorer diagnostic and treatment uptake by migrants.
Migrants are therefore less likely to be diagnosed at an early stage of HIV infection and are more likely to be LTFU at successive stages of the HIV treatment cascade.
Timely progress and long-term retention in the HIV treatment cascade can be facilitated by improvements in migrant health monitoring systems, an emphasis on the human right to health regardless of citizenship or legal status and the integration of migrant-specific health services into the broader public health framework of the host country. [42] [43] [44] [45] . In some cases, timely entry into the healthcare system was complicated by a lack of knowledge about the necessary administrative procedures and an inability to communicate effectively in the native language experiences that were further compounded by a significant amount of effort and skill required to access relevant HIV care services in the first place [16 & ,38,46,47,48 && ,49]. Access to HIV testing was not always facilitated by service providers in the healthcare system itself. In a recent study, only one-half of 31 European countries surveyed offered voluntary HIV testing to migrants despite acknowledging the merits of this service [50] . In turn, circulatory migrants and frequent travelers could not be easily reached by service providers seeking to undertake HIV testing and counseling [51] .
Given the dramatic change in their life course, newly arriving migrants often felt the need to connect with compatriot groups, and described a strong pressure to conform to the social norms and beliefs of the group [48 && ,52]. For this reason, a reluctance to know one's HIV status was strongly linked with the fear of disclosure and exclusion from the compatriot group as a result [48 && ,52,53] . The decision to delay testing was also linked to the legal implications of an HIV-positive test, which some migrants believed would lead to deportation or the revoking of a visa or residence application [53] [54] [55] [56] . Further factors associated with low testing uptake and late HIV diagnosis for migrants were high levels of unemployment, low social status, violence and socioeconomic inequalities [43, 45, 49] . These factors represent missed opportunities to increase the levels of HIV testing and show the need for policies that offer voluntary HIV testing and counseling to migrants.
Retention in HIV care
Migrants also face challenges in linking to and remaining in HIV treatment. Barriers which reduced linkage to, and retention within, the healthcare system were associated with unfamiliarity with the new host environment, miscommunication with HIV service providers and a lack of knowledge about patient rights and obligations [48 && ]. Differences in the health-seeking behaviors of migrants were also reported; for example, individuals tended to seek care only once they felt sick or showed severe symptoms [18, 55, 57] . Further, the health seeking behaviors of immigrants or migrants were not always fully understood by the host service-providers, who at times were described as displaying a lack of cultural sensitivity [52, [57] [58] [59] [60] . Often, these experiences led to feelings of distrust or a lack of control, which sometimes resulted in migrants seeking treatment and care advice from sources outside the healthcare system [43,48 && ]. Several barriers have also been associated with poor virologic suppression, many of which are further exacerbated by the high mobility of individuals, typically in the form of frequent travel, travel for care, work-related travel, transnational travel, and circular migration [16 & ,41 && ,61] . Continual engagement with the healthcare system at this stage of the treatment cascade is necessitated by the need to collect and refill medication supplies on a routine basis. Circulatory migrants are especially vulnerable to treatment interruption. Such individuals report not taking their pills consistently because of a fear of side-effects while traveling, difficulties in finding clean water or food to aid the ingestion of pills, and a preference to delay taking pills until the destination is reached [16 & ]. HIV-positive individuals who traveled frequently to family events described a reluctance to take their medications around family members and in some cases resorted to hiding their pills in bottles with different labels so as to not disclose their status [62, 63] . One important barrier to treatment adherence was related to the site where an individual registered and initiated ART. In these cases, individuals would have to overcome the difficulties in identifying new sites to access medication, which often involved additional administrative procedures, navigating public transport schedules and routes, overcoming public transport services that do not take individuals all the way to the clinic, the rising costs of travel to the clinic and a number of other transport-related barriers [16 & ,49,64,65] . In the USA, migrants typically reported exhausting their supply of pills while traveling for periods greater than 1 month [16 & ,66 ]. An extensive review of the literature on transnational migrants in low-income and middle-income countries described barriers and facilitators to HIV services and raised concerns about the manner in which the healthcare systems of developing countries struggled keep up with the increasing range of migration flows [67] .
STRATEGIES TO IMPROVE MIGRANTS' PROGRESSION THROUGH THE HIV TREATMENT CASCADE
An effective strategy to begin to address the problems discussed above is to more accurately monitor migrant health. The development of standardized and reproducible data categories to describe migrants is useful and could assist in the measurement of the impact of migration on the healthcare system. To collect migrant-relevant information, novel approaches will need to be added to existing routine data collection infrastructures both in health systems and in population-based health research.
Monitoring of migrant health
To facilitate uninterrupted access to treatment and to be able to provide realistic estimates at each step of the cascade, it is important that mobile populations are able to easily receive their HIV treatment at different facilities both within and between countries. Seamless record linkage via a centralized database can contribute to ensuring that HIV treatment is not interrupted by migration. Such record linkage across space and time is increasingly being done even in African settings [68] [69] [70] [71] . One area that improvements in monitoring migrant systems could be useful is the loss to follow-up of infected individuals in the healthcare system. Research has shown that migrants and mobile individuals are at a significantly higher risk of being lost to follow-up (LTFU) within ART programs [28, 29, 33, 36] . However, research has begun to show that only a proportion of those declared to be LTFU actually disengage from care [37] . For instance, a study in the USA showed people who migrated to another county within the USA often reengaged in HIV care at other clinics. Therefore, adjusting for outmigration in addition to mortality was shown to be crucial for the valid estimation of LTFU rates [37] . A study focusing on the effect of out-migration on the estimates of retention in care over 5 years following HIV diagnosis in the USA concluded that the retention in care rates would be underestimated unless out-migration and death were taken into account [72 & ]. A meta-analysis of 28 studies of patients of 258 ART clinics in sub-Saharan Africa found that 20% of the ART patients reported as LTFU had, in fact, self-transferred to a different clinic and have remained engaged in ART care [15] . Therefore, assessments of the HIV treatment cascade must involve linking health records of individuals across healthcare locations, otherwise LTFU rates would likely be overestimated, and ART retention rates underestimated. It would be important for the employment of data collection to consider the challenges of data collection on migrants, and potential concerns migrants may have about their data being used for deportation purposes of fear of discrimination or other negative interaction with authorities.
One important avenue to pursue is the ability to use mobile technology to improve monitoring systems. The ability to track migrants as they move from one area to another area is essential to assure their continued HIV care, as well as for HIV surveillance. Based on the figures released by the International Communication Union, the worldwide penetration rate of cellular phones will be 97% with more than 7 billion subscriptions [73] . As migrants are likely to retain their cellular phone service when changing residences, the mobile phone technology hold an immense potential to facilitate the interaction between healthcare providers and HIVinfected patients in need of lifelong care. Mobile health (mHealth) focuses on the use of mobile phone technology to improve health outcomes and deliver healthcare. A key application supported by the WHO involves using text messaging to improve adherence to ART. Table 2 [60, [74] [75] [76] [77] [78] [79] [80] [81] [82] summarizes some of the current evidence about the efficacy of mHealth in HIV care.
Despite the unquestionable widespread adoption of cellular technology, some studies have shown uncertain evidence that text messages improve ART adherence even in high-risk populations [76, 77] . Scaling up mHealth applications involve major challenges related to their dependency on funding sources, unreliable infrastructure, fast-evolving technology and their harmonization with existing healthcare systems [71] . Positive outcomes of the use of mHealth, however, have started to emerge; new evidence suggests that the delivery of support by cellular phones is accepted by youth ages 15-24 years nonadherent to ART [82] . This is an important finding as adolescents (especially girls) are a key high-risk population, which deals with major challenges in reducing their risk of HIV acquisition and linking to healthcare [83] . The efficacy of mHealth solutions can be improved by utilizing fewer text messages whose content and timing are customized for each individual, and inquire about their well-being instead of conveying plain reminders about medications [78, 81] . Solutions that encourage individuals to respond to the text messages sent to them also seem to be more effective [79] .
Access to healthcare for migrants
At the present time, existing public health systems fail to properly account for migration, and Bärnighausen et al. [74] This study reviews 26 studies of ART adherenceenhancing interventions in sub-Saharan Africa, including mobile phone text messages for ART adherence
Mobile phone text messages significantly improved ART adherence in two large, well conducted controlled trials
Chaiyachati et al. [75] This study reviews the global evidence on ARTenhancing interventions (124 studies)
Provides evidence that mobile phone messages and other reminders can significantly improve ART adherence in many settings
Mbuagbaw et al. [76] This is a randomized two-arm trial in Yaounde, Cameroon, designed to test the efficacy of a weekly standardized motivational mobile phone text messages for ART adherence and continuation of HIV treatment ART adherence did not significantly improve for patients who received motivational text messages after 6 months
Catalani et al. [77] This study reviews 62 papers focusing on employing mHealth for linkage and retention to HIV care, and ART adherence
Although there is qualitative evidence that mHealth tools are potentially useful, there is little to no evidence about the efficacy of these tools to aid high-risk populations such as pregnant women, sex workers, drug users or MSM Lester [78] Discusses five studies of the use of mHealth to improve HIV treatment adherence
Patients seem to prefer shorter mobile communication that makes them feel cared for to longer explicit reminders about their treatment
Mbuagbaw et al. [79] This is a study of the two-way mobile communications (calls and text messages) between patients and healthcare providers in a randomized two-arm trial [76] The efficacy of mHealth tools in improving HIV treatment adherence could be improved by including features that allow patients to respond to mobile communications from healthcare providers Aranda-Jan et al. [80] Review of 44 studies on the use of mHealth tools in Africa, out of which 19 were dedicated to ART adherence and patient follow-up mHealth tools are low cost options to improve ART adherence, service delivery and health workers' adherence to clinical guidelines. However, many challenges arise when attempting to scale up mHealth projects
Finitsis et al. [81] Meta-analysis of 9 text-messaging interventions designed to improve ART adherence mHealth tools that achieved larger improvement rates in ART adherence involved fewer text messages and encouraged patients to respond back. The frequency of text messages, their specific content and their timing should be tailored to match individual preferences
Belzer et al. [82] This study describes a randomized clinical trial of young patients nonadherent to ART that took place in five US cities that involved daily cell phone support
Young patients seem to respond positively to receiving support by cell phones, which significantly improved their self-reported ART adherence. Although the cost of providing phones to patients might seem high, this cost is actually low with respect to the cost of ART nonadherence ART, antiretroviral therapy; mHealth, mobile health; MSM, men who have sex with men.
actionable knowledge of migration is still lacking [61] . This observation has enormous implications in terms of defining new policies for improving the HIV care continuum in which assuring treatment continuity for migrants is of utmost importance. UNAIDS has recently formulated key recommendations for national and international policies that facilitate continued access of migrants to the HIV treatment cascade [27] . The organization called for the implementation of customized HIV care programs with increased effectiveness in addressing the needs of specific groups of migrants (e.g., circular labor migrants, international migrants, people who visit their country of origin and internal migrants who move from one administrative area to another). Cultural, language and stigma-related barriers to care must be properly taken into consideration when designing care programs. UNAIDS argued for the need to end any discrimination for access to care between migrants and nonmigrants. Appropriate treatment and counseling should be offered to migrants who should be free to refuse in case if they so desire. Mandatory HIV testing should be eliminated, together with any restrictions related to the entry, stay and residence of people known to be HIV positive. UNAIDS also called for crosscountry efforts to create HIV care programs that reduce treatment interruptions for international migrants. The families of migrants must be included in the care programs, as they are at an increased vulnerability to acquisition of HIV.
CONCLUSION
Migrants and mobile individuals represent a large and diverse group who have changing healthcare needs. At the present time, public health systems fail to properly account for migration, and actionable knowledge of the health requirements of migrants is still lacking [53] . A significant body of research has been devoted to the HIV treatment cascade, but our understanding of the challenges experienced by migrants is incomplete. There are a number of areas in which future research on HIV treatment and care services for migrants should be developed. One of these is the establishment of a centralized health information system that could be used to more accurately determine the state of health of HIVinfected migrants and their interaction with the healthcare system. In this regard, research initiatives should focus on the challenges associated with the implementation and management of such systems. Attention could be devoted to whether the information generated from these data systems can improve linkage to care and retention within the HIV treatment cascade. Such information could in turn be disseminated to other sectors of the healthcare systems, or shared with other government planning departments and public health agencies to address existing gaps in service delivery. Improvements in data collection could also provide an opportunity for researchers to identify hidden disparities or inequalities in migrant healthcare access and quantify the determinants associated with loss to follow-up at successive stages of the treatment cascade. In this regard, research should focus on identifying the largest 'leaks' in the treatment cascade area and proposing how these may be addressed. ]. Another systematic review of Latino migrants in the USA could not find any articles reporting linkage or retention to care by birth country or region [85] .
An important and recurrent theme that we encountered in our review was that of the sensitivity of the healthcare system to the migrants' needs. Here, research should be orientated toward efforts or interventions designed to minimize the negative impact of migration, as well as the disparities that affect access to health services. One area of focus could be the evaluation of programs to tailor HIV care services to fit the cultural needs or expectations of migrants. Such initiatives could include improvements to language and interpretation resources, including the delivery of health services to migrants in a culturally and linguistically appropriate manner. One aspect of migrant-sensitive care could be related to staff training, as well as diversification of staff labor; for example, existence of multicultural staff has been perceived as a strength by migrant patients. [86] In addition, research initiatives can continue to expand on the barriers to care associated with the legal and undocumented status of HIVpositive migrants. Improved outreach efforts to inform individuals of the human right to health may or may not alleviate the concerns of migrants, which may improve equal access to health services. Ultimately, opportunities for research would link to a broader question of whether migrant HIV services can be integrated into existing structures and services, rather than existing as parallel services. The movement of individuals through the treatment cascade provides a demonstrable context for which to evaluate the success of health services in host countries to achieve this level of integration.
The actual and perceived legal status of the HIVinfected migrants has been identified as an important theme throughout this review. High levels of human mobility and international migration are likely to continue into the foreseeable future. Member states of the WHO have endorsed resolutions to respect the rights of migrants to health services regardless of legal status [87] . In the past, a large number of European countries have restricted access to nonemergency services as a way to discourage the entry of new migrants [88] . To this extent, health services for migrants are often informed by the broader immigration policy regimes of the host country [89] . In response to binding resolutions, many nation states will have to consider adapting their existing structures and institutions to accommodate the healthcare needs of migrants in an increasingly globalized world. Research initiatives to document the transition of healthcare systems from an exclusive to an inclusive and multidimensional approach will be important.
